Recruiting OBSERVATIONAL NCT07206095
Integrative Diagnosis for SCD and Other RADs (INTEGRA)
Integrative Diagnosis of Sickle Cell Disease (SCD) and Other Rare Anemia Disorders (RADs) for Personalized Medicine
Sponsor: Hospital Arnau de Vilanova, Lleida (Spain)
Conditions
Anemia Due to Membrane Defect Congenital Dyserythropoietic Anemia (CDA) Enzyme Disorder; Anemia Hemoglobin Disorder Rare Anemia Disorders Sickle Cell Disease Spherocytosis, Hereditary Stomatocytosis Thalassaemia
Interventions
Analysis of genetic modifiers Disease phenotyping
Updated 1 time since 2025 Last updated: Sep 25, 2025 Started: Nov 13, 2020 Primary completion: May 25, 2025 Completion: May 31, 2028
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT07206095, this observational or N/A phase trial focuses on Anemia Due to Membrane Defect and Congenital Dyserythropoietic Anemia (CDA) and remains actively recruiting participants. Sponsored by Hospital Arnau de Vilanova, Lleida (Spain), it has been updated 1 time since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
1 version recorded Recruiting
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Hospital Arnau de Vilanova, Lleida (Spain)
- Hospital Clinic de Barcelona, Barcelona, Spain
- Hospital Universitari Vall d'Hebron Research Institute
- Institute for Bioengineering of Catalonia
Data source: Hospital Universitari Vall d'Hebron Research Institute
For direct contact, visit the study record on ClinicalTrials.gov .